Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro

With the development of the COVID-19 epidemic, there is an urgent need to establish a system for determining the effectiveness and neutralizing activity of vaccine candidates in biosafety level 2 (BSL-2) facilities. Previously, researchers had developed a pseudotyped virus system for SARS-CoV and ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ren, Huang, Baoying, A, Ruhan, Li, Wenhui, Wang, Wenling, Deng, Yao, Tan, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442068/
https://www.ncbi.nlm.nih.gov/pubmed/32864605
http://dx.doi.org/10.1016/j.bsheal.2020.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442068/
https://www.ncbi.nlm.nih.gov/pubmed/32864605
http://dx.doi.org/10.1016/j.bsheal.2020.08.004

Ejemplares similares